Familial antiphospholipid antibody syndrome: Criteria for disease and evidence for autosomal dominant inheritance

Arthritis and Rheumatism

Volumn 42, Issue 2, 1999, Pages 318-327

  Goel, Niti ^a   Ortel, Thomas L ^a   Bali, Deeksha ^a   Anderson, Joshua P ^g   Gourley, Ian S ^a   Smith, Howard ^b   Morris, Colleen A ^g   DeSimone, Muriel ^g   Ware Branch, D ^c   Ford, Peter ^d   Berdeaux, Donald ^e   Roubey, Robert A S ^g   Kostyu, Donna D ^a   Kingsmore, Stephen F ^a   Thiel, Tracy ^g   Amos, Christopher ^f   Seldin, Michael F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Huron Hospital   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d QUEEN S UNIVERSITY   (Canada)

^e USAF Medical Center Keesler   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g Duke University Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; FAS LIGAND; HLA ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; DISEASE ASSOCIATION; FAMILIAL DISEASE; FEMALE; GENE SEGREGATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INHERITANCE; MAJOR CLINICAL STUDY; MALE; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; SCORING SYSTEM; SERODIAGNOSIS;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENES, DOMINANT; HISTOCOMPATIBILITY TESTING; HLA-D ANTIGENS; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; MODELS, GENETIC; PEDIGREE; POLYMERASE CHAIN REACTION;

EID: 0033007174     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199902)42:2<318::AID-ANR15>3.0.CO;2-5     Document Type: Article

References (44)

1. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;2:1211-4.
2. Lockshin MD. Antiphospholipid antibody syndrome. Rheum Dis Clin North Am 1994;20:45-59.
3. Sammaritano LR, Gharavi AE, Lockshin MD. Antiphospholipid antibody syndrome: immunologic and clinical aspects. Semin Arthritis Rheum 1990;20:81-96.
4. Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, Lopez-Soto A, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med 1994;96:3-9.
5. Exner T, Barber S, Kronenberg H, Rickard KA. Familial association of the lupus anticoagulant. Br J Haematol 1980;45:89-96.
6. Mackworth-Young C, Chan J, Harris N, Walport M, Bernstein R, Batchelor R, et al. High incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus. J Rheumatol 1987;14:723-6.
7. Goldberg SN, Conti-Kelly AM, Greco TP. A family study of anticardiolipin antibodies and associated clinical conditions. Am J Med 1995;98:473-9.
8. Mackie IJ, Colaco CB, Machin SJ. Familial lupus anticoagulants. Br J Haematol 1987;67:359-63.
9. Ford PM, Brunet D, Lillicrap DP, Ford SE. Premature stroke in a family with lupus anticoagulant and antiphospholipid antibodies. Stroke 1990;21:66-71.
10. Pettee AD, Wasserman BA, Adams NL, McMullen W, Smith HR, Woods SL, et al. Familial Sneddon's syndrome: clinical, hematologic, and radiographic findings in two brothers. Neurology 1994; 44:399-405.
11. Bansal AS, Hogan PG, Gibbs H, Frazer IH. Familial primary antiphospholipid antibody syndrome [letter]. Arthritis Rheum 1996;39:705-6.
12. Matthey F, Walshe K, Mackie IJ, Machin SJ. Familial occurrence of the antiphospholipid antibody syndrome. J Clin Pathol 1989;42: 495-7.
13. Dagenis P, Urowitz MB, Gladman DD, Notman CS. A family study of the antiphospholipid antibody syndrome associated with other autoimmune diseases. J Rheumatol 1992;19:1393-6.
14. Trabace S, Nicotra M, Cappellacci S, Morellini M, Mutinelli C, Sbracia M, et al. HLA-DR and DQ antigens and anticardiolipin antibodies in women with recurrent spontaneous abortions. Am J Reprod Immunol 1991;26:147-9.
15. Asherson RA, Doherty DG, Vergani D, Khamashta MA, Hughes GRV, Major histocompatibility complex associations with primary antiphospholipid syndrome. Arthritis Rheum 1992;35:124-5.
16. Savi M, Ferroccioli GF, Neri TM, Zanelli P, Dall'Aglio PP, Tincani A, et al. HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. Arthritis Rheum 1988;31:1568-70.
17. McHugh NJ, Maddison PJ. HLA-DR antigens and anticardiolipin antibodies in patients with systemic lupus erythematosus [letter]. Arthritis Rheum 1989;32:1623-4.
18. Hartung K, Coldeway R, Corvetta A, Deicher H, Kalden JR, Krapf F, et al. MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus: results of a multicenter study. Autoimmunity 1992;13:95-9.
19. Granados J, Vargas-Alarcón G, Drenkard C, Andrade F, Melin-Aldana H, Alcocer-Varela J, et al. Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE). Lupus 1997;6:57-62.
20. Arnett FC, Olsen ML, Anderson KL, Reveille JD. Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant. J Clin Invest 1991;87:1490-5.
21. Gulko PS, Reveille JD, Koopman WJ, Burgard SL, Bartolucci AA, Alarcón GS. Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations, and impact on survival. J Rheumatol 1993;20:1684-93.
22. Wilson WA, Perez MC, Michalski JP, Armatis PE. Cardiolipin antibodies and null alleles of C4 in black Americans with systemic lupus erythematosus. J Rheumatol 1988;15:1768-72.
23. Arnett FC, Reveille JD, Wilson RW, Provost TT, Bias WB. Systemic lupus erythematosus: current state of the genetic hypothesis. Semin Arthritis Rheum 1984;14:24-35.
24. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory; 1989.
25. Brandt JT, Triplett DA, Alving B, Scharrer I, on behalf of the Subcommittee on Lupus Anticoagulant, Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995;74:1185-90.
26. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 1985;62:738-45.
27. 2-glycoprotein I and a conventional anticardiolipin immunoassay. Arthritis Rheum 1996;39:1606-7.
28. Petri M. Diagnosis of antiphospholipid antibodies. Rheum Dis Clin North Am 1994;20:443-69.
29. Kostyu DD, Pfohl J, Ward FE, Lee J, Murray A, Amos DB. Rapid HLA-DR oligotyping by an enzyme-linked immunosorbent assay performed in microtiter trays. Hum Immunol 1993;38:148-58.
30. Reed PW, Davies JL, Copeman JB, Bennett ST, Palmer SM, Pritchard LE, et al. Chromosome-specific microsatellite sets for fluorescence-based, semi-automated genome mapping. Nat Genet 1994;7:390-5.
31. PEDSYS. A pedigree data management system: user's manual, PCL technical report number 2. San Antonio (TX): Population Genetics Laboratory, Department of Genetics, Southwest Foundation for Biomedical Research: 1994.
32. Nichols WC, Amano K, Cacheris PM, Figueiredo MS, Michaelides K, Schwaab R, et al. Moderation of hemophilia A phenotype by the factor V R506Q mutation. Blood 1996;88:1183-7.
33. S.A.G.E. Statistical analysis for genetic epidemiology [computer program]. Version 2.1. New Orleans: LSU Medical Center; 1992.
34. Cannings C, Thompson EA. Ascertainment in the sequential sampling of pedigrees. Clin Genet 1977;12:208-12.
35. Lathrop GM, Lalouel JM, Julier C, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A 1984;81: 3443-6.
36. Ploughman LM, Boehake M. Estimating the power of a proposed linkage study for a complex genetic trait. Am J Hum Genet 1989;44:543-51.
37. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero J, et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989;68:366-74.
38. Piette JC. Diagnostic and classification criteria for the antiphospholipid cofactors syndrome - a mission impossible. Lupus 1996;5:354-63.
39. Simantov R, Lo SK, Salmon JE, Sammaritano LR, Silverstein RL. Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies. Thromb Res 1996;84:361-5.
40. Dizon-Townson D, Hutchison C, Silver R, Branch DW, Ward K. The factor V Leiden mutation which predisposes to thrombosis is not common in patients with antiphospholipid antibodies. Thromb Haemost 1995;74:1029-31.
41. Briley F, Bentolila S, Poirier JC, Marcelli A, Nicaise P, Labarre C, et al. High familial anticardiolipin antibody titer and major histocompatibility complex. Thromb Haemost 1996;76:1118-9.
42. Hudson N, Busque L, Rauch J, Kassis J, Fortin PR. Familial antiphospholipid syndrome and HLA-DRB gene associations. Arthritis Rheum 1997;40:19117-8.
43. S.A.G.E. Statistical analysis for genetic epidemiology [computer program]. Version 3.1. New Orleans: LSU Medical Center; 1997.
44. Crassard I, Biousse V, Michel C, Bletry O, Piette AM, Labauge P, ct al. Familial primary antiphospholipid syndrome [abstract]. Arthritis Rheum 1996;39 Suppl 9:S97.